Michel Goldman is Professor of Medical Immunology and co-Director of the I3h Institute, Université libre de Bruxelles. He is a former Executive Director of the Innovative Medicines Initiative.

VoxEU Column
Improving the innovation/access trade-off for rare diseases in the EU after Covid-19
-

- Health Economics 
- Productivity and Innovation

VoxEU Column
How to strengthen European industries’ leadership in vaccine research and innovation
-

- COVID-19 
- EU policies 
- Health Economics

VoxEU Column
Rapidly identifying workers who are immune to COVID-19 and virus-free is a priority for restarting the economy
-

- Health Economics 
- COVID-19 
- Global economy